Latest news with #UniversityCollegeLondonHospitalstrust
Canada News.Net
03-08-2025
- Business
- Canada News.Net
Neuralink to test brain implant in UK for spinal injury patients
FREMONT, California: Elon Musk's Neuralink is taking its brain-computer interface technology to the UK, with a clinical trial aimed at helping patients with severe paralysis operate devices using only their thoughts. The company announced it will partner with the University College London Hospitals trust and Newcastle Hospitals to conduct the study. Neuralink said the trial will involve patients suffering from conditions like spinal cord injuries and Amyotrophic Lateral Sclerosis (ALS). These individuals may qualify to test the company's implant, which is designed to enable control of digital and physical tools via brain signals. The UK study comes as part of Neuralink's broader efforts to scale human testing of its brain chip. The company began human trials in 2024 after addressing safety issues flagged by the U.S. Food and Drug Administration, which initially rejected its application in 2022. According to Neuralink, five patients with severe paralysis are already using the device to control external tools with their thoughts. Founded in 2016, Neuralink has raised about US$1.3 billion from investors and is reportedly valued at approximately $9 billion, according to PitchBook data cited in media reports. Last month, the company secured $650 million in fresh funding to advance its work on brain-machine interfaces.
Hindustan Times
01-08-2025
- Business
- Hindustan Times
Elon Musk's Neuralink partners with UK hospitals to test brain chips
Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts. The company is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study.(Reuters) The company is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study, it said in a post on X. Neuralink said patients living with paralysis due to conditions such as spinal cord injury and a nervous system disease called Amyotrophic Lateral Sclerosis (ALS) qualify to participate in the study. Also read: Elon Musk reacts as Neuralink recipient writes her name using only thoughts after 20 years: 'This is possible' The company raised $650 million in its latest funding round last month. It began human trials in 2024 on its brain implant after resolving safety concerns flagged by the U.S. Food and Drug Administration, which had initially rejected Neuralink's application in 2022. According to the company, five patients with severe paralysis are currently using its device to control digital and physical tools with their thoughts. Neuralink, founded in 2016, has raised about $1.3 billion from investors and is valued at roughly $9 billion, according to media reports, citing PitchBook.
Time of India
01-08-2025
- Health
- Time of India
Musk's Neuralink to test brain chips in clinical study in Great Britain
Bengaluru: Elon Musk 's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts. The company is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study, it said in a post on X. Neuralink said patients living with paralysis due to conditions such as spinal cord injury and a nervous system disease called Amyotrophic Lateral Sclerosis (ALS) qualify to participate in the study. The company raised $650 million in its latest funding round last month. It began human trials in 2024 on its brain implant after resolving safety concerns flagged by the U.S. Food and Drug Administration, which had initially rejected Neuralink's application in 2022. According to the company, five patients with severe paralysis are currently using its device to control digital and physical tools with their thoughts.
